AOM prescribing increased in December 2025 compared to September 2025 (+10.1%)
Thirteen states cover GLP-1s for obesity treatment under Medicaid, according to a January 2026 report from KFF, a nonpartisan research organization focused on health policy
ends 8/31 give $100, get $100 microneedling results, upgraded explore custom catalyst serums award-winning treatments face & body Highly-trained experts Medical Professionals Safe, trusted, and medically-tested treatments
Owing to the short plasma half-life of GLP1, several GLP1 receptor agonists (GLP1RAs) were developed with different chemical structures and pharmacokinetic profiles for type 2 diabetes mellitus (T2DM) treatment
Use morning and night, under SPF during the day
The exact contribution of GIP to retatrutide-associated weight reduction is still being studied